Dividends & Buybacks ·
Novo Nordisk repurchases 1.4M B shares for DKK 387M in weekly update
NONOFNovo Nordisk A S
Novo Nordisk provided a routine progress report on its share repurchase programme, detailing transactions executed between October 26 and November 2, 2026. The company bought an additional 1,440,000 B shares at an average price of DKK 263.59, adding approximately DKK 387 million to the total spend. Since February 4, 2026, Novo Nordisk has repurchased a cumulative 41,714,179 B shares for DKK 11.56 billion, holding 55,754,876 treasury shares representing 1.2% of capital. The company aims to spend up to DKK 15 billion over the 12-month period ending February 3, 2027. Novo Nordisk is a global healthcare company developing treatments for diabetes, obesity, and other chronic diseases.